On August 30, 2018 IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") reported that its Chief Financial Officer, Andre Godin, is scheduled to present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 6, 2018 at 2:35 p.m. Eastern Time at the St. Regis New York (Press release, IntelGenx, AUG 30, 2018, View Source;Renshaw-Global-Investment-Conference/default.aspx [SID1234529179]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Godin will provide an overview of IntelGenx’s business during the presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will be webcast live and archived for 90 days on the Company’s website, www.intelgenx.com, under "Investors".

On August 30, 2018 Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) ("Rocket"), a leading U.S.-based multi-platform gene therapy company, reported that members of Rocket’s executive team will participate in the following upcoming investor conferences (Press release, Rocket Pharmaceuticals, AUG 30, 2018, View Source [SID1234529197]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 13th Annual Biotech Conference on September 6, 2018 in Boston, MA
Morgan Stanley 16th Annual Global Healthcare Conference on September 13, 2018 at 5:15 p.m. Eastern Time in New York, NY

A live audio webcast of the Morgan Stanley fireside chat will be available on the Investors section of the company’s website, www.rocketpharma.com. A replay of the presentation will be archived on the Rocket website following the conference.

On August 30, 2018 Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO)
Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor
engineered T cell (CAR T) technology and gene therapies for rare diseases, reported that Manuel Litchman, M.D.,President and Chief Executive Officer, will participate in two investor conferences in September (Press release, Mustang Bio, AUG 30, 2018, View Source [SID1234529163]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

• B. Riley FBR Annual Healthcare Conference panel presentation entitled, "A Beginner’s Guide to T-Cell Cancer
Therapy" on Tuesday, September 4, 2018, at 1:55 p.m. EDT at the New York Marriott East Side in New York City
• 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC,
company presentation on Thursday, September 6, 2018, at 3:25 p.m. EDT at the St. Regis New York in New York
City

On August 30, 2018 Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on novel therapies in oncology, reported that senior management will present at the following upcoming investor conferences (Press release, Immune Design, AUG 30, 2018, View Source [SID1234529181]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

13th Annual Wells Fargo Securities Healthcare Conference
Wednesday, September 5, 2018 at 1:50 p.m. Eastern Time in Boston.

H.C. Wainwright & Co. 20th Annual Global Investment Conference
Thursday, September 6, 2018 at 10:50 a.m. Eastern Time in New York.

A live webcast of each presentation will be available online from the investor relations page of the company’s corporate website at View Source After the live webcast, an archive of each presentation will be available on the company website for 30 days.

On August 30, 2018 Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, reported that Derek Maetzold, President and CEO, will present at the Baird Global Healthcare Conference on Wednesday, September 5th, 2018 at 11:25 a.m. ET in New York City (Press release, Castle Biosciences, AUG 30, 2018, View Source [SID1234529198]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!